Extreme sensitivity to Yondelis® (Trabec
✍
Victoria Moneo; Beatriz G. Serelde; Jesús Fominaya; Juan F.M. Leal; Carmen Blanc
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 176 KB
## Abstract Yondelis® (Trabectedin, ET‐743) is a marine anticancer agent currently in Phase II/III development in patients with advanced pretreated soft tissue sarcoma. In the present study, we generated a panel of low passaged tumor cell lines from samples explanted from chemonaive sarcoma patient